112 related articles for article (PubMed ID: 5781334)
1. [Study of gastric secretory function and its inhibition with Xylamide. The maximal acid output (MAO) test and the Hollander test].
Arias Vallejo E; Diaz G; Moreno Arranz B; Lozano L
Minerva Med; 1969 Mar; 60(23):1063-9. PubMed ID: 5781334
[No Abstract] [Full Text] [Related]
2. [Clinical study of a new anti-ulcer drug: CR-242, Xylamide, in 23 cases].
Uzeta Mejia S
Minerva Med; 1969 Mar; 60(23):1070-3. PubMed ID: 5781335
[No Abstract] [Full Text] [Related]
3. [Therapeutic activity in gastric and duodenal ulcers, gastritis and gastroduodenitis of an anti-secretory, non-anticholinergic drug].
Bianchi PG; Saccabusi E
Minerva Med; 1969 Mar; 60(23):1044-52. PubMed ID: 5781331
[No Abstract] [Full Text] [Related]
4. [Inhibiting effects of Xylamide on induced maximal gastric acid secretion in humans].
Sampietro R
Minerva Med; 1969 Mar; 60(23):1032-7. PubMed ID: 5781329
[No Abstract] [Full Text] [Related]
5. [Clinical experiences with CR-242, Xylamide, in the treatment of gastroduodenal ulcerous disease. Study of 30 cases].
Arias Vallejo E; Diaz G; Moreno Arranz B; Lozano L
Minerva Med; 1969 Mar; 60(23):1057-62. PubMed ID: 5781333
[No Abstract] [Full Text] [Related]
6. [Therapy of gastro-duodenal ulcer, gastritis and gastroduodenitis with an antisecretory, non-anticholinergic drug (Milid)].
Borellini D; Milvio C
Minerva Med; 1969 Mar; 60(23):1053-6. PubMed ID: 5781332
[No Abstract] [Full Text] [Related]
7. [Clinical trials of a pharmacological perparation in the therapy of ulcerous gastroduodenitis].
Linati E
Minerva Med; 1969 Mar; 60(23):1038-43. PubMed ID: 5781330
[No Abstract] [Full Text] [Related]
8. [Evaluation of the therapeutic activity of CR 242 or Xylamide in the treatment of gastric and duodenal ulcers and of gastroduodenitis].
Bellomo A; Strobbia R; Manzoni A
Minerva Med; 1969 Mar; 60(23):1024-31. PubMed ID: 5781328
[No Abstract] [Full Text] [Related]
9. [Xylamide (Milid) therapy of gastroduodenitis in patients with saturnism].
Gambini G; Grisler R
Minerva Med; 1969 Mar; 60(23):1017-23. PubMed ID: 5781327
[No Abstract] [Full Text] [Related]
10. [Use of Xylamide (MILID) as an antisecretory-antigastrinic agent in acute pancreatitis].
Margnelli M; Zacco R; Velati GF
Minerva Gastroenterol; 1969; 15(4):229-34. PubMed ID: 5379889
[No Abstract] [Full Text] [Related]
11. [Evaluation of the antigastrin effect of xilamide].
Laudano OM
Prensa Med Argent; 1968 Nov; 55(40):1896-8. PubMed ID: 5714058
[No Abstract] [Full Text] [Related]
12. Inhibition of gastric acid secretion in man by peptide analogues of cholecystokinin.
Brooks AM; Agosti A; Bertaccini G; Grossman MI
N Engl J Med; 1970 Mar; 282(10):535-8. PubMed ID: 5460986
[No Abstract] [Full Text] [Related]
13. [Activity-structure relationship in compounds with antigastrin activity].
Andrási F; Borsy J; Farkas L
Acta Pharm Hung; 1973 Jul; 43(3):116-20. PubMed ID: 4747707
[No Abstract] [Full Text] [Related]
14. [Pharmacological and clinical studies of a non-anticholinergic antisecretory product: Milid (xylamide, CR 242)].
Mainoli S; Milvio C; Borellini D
Minerva Med; 1967 Oct; 58(86):3708-12. PubMed ID: 6061066
[No Abstract] [Full Text] [Related]
15. Pharmacological studies on an antigastrin and antiulcer agent, SC-15396.
Bianchi RG; Cook DL
Fed Proc; 1968; 27(6):1331-6. PubMed ID: 5725225
[No Abstract] [Full Text] [Related]
16. [The effect of ACTH on the secretion of gastromucoproteins and other components of gastric juice].
Khitarov MZ
Vrach Delo; 1968 Nov; 11():129-30. PubMed ID: 4314873
[No Abstract] [Full Text] [Related]
17. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
[TBL] [Abstract][Full Text] [Related]
18. [Gastric anti-secretory activity of pifarnine. Preliminary clinical study].
Ghidini O; Residori P; Magnani P
Clin Ter; 1979 Oct; 91(2):187-95. PubMed ID: 540480
[No Abstract] [Full Text] [Related]
19. [Therapeutic value of the combination of a corticosteroid (prednisone) with a gastroprotective substance (xylamide)].
Abbona C; Marugo M; Berretti A
Minerva Med; 1972 Sep; 63(60):3258-65. PubMed ID: 4559865
[No Abstract] [Full Text] [Related]
20. [Pathophysiology and drug therapy of peptic ulcer].
Yamagata S
Nihon Ishikai Zasshi; 1970 Jan; 63(2):157-83. PubMed ID: 5462365
[No Abstract] [Full Text] [Related]
[Next] [New Search]
